Literature DB >> 6375634

The biologic basis for the clinical application of the silicones. A correlate to their biocompatibility.

M B Habal.   

Abstract

The polysiloxanes (silicones) are a group of inert and inorganic compounds that were introduced over two decades ago. The pure form, termed medical-grade silicone, has a wide variety of clinical applications. Almost all surgical fields have used a product made of silicone. Silicone has been found to be an inert material, with minimal reaction of the biologic system to its presence. However, multiple clinical problems still exist due to certain applications of silicone products. The problems are related to its surface properties; In the blood thrombi form around silicone implants that may dislodge and cause symptoms around the implants. Scar formation may occur, and internal wound healing problems in the breast cause spherical contracture. In the eyes, where transparencies are needed, as in the intraocular lens implant, the scar interfaces with the visual image transmissions. Some of these internal problems relate to the hydrophobic nature of the silicone surface and have been resolved in part by adsorbing a wetting agent, such as povidone, to the surface. Such obviation has gained wide clinical application in surface coating of the intraocular lens. In search of an ideal implantable material, silicone, the most applicable, is still far from being called the ideal implant. Perhaps with the changes of its surface properties, such as introducing wetting agents to its surface, a new dimension in clinical applications will open the horizons of silicone in the 1980s.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6375634     DOI: 10.1001/archsurg.1984.01390190081019

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  9 in total

1.  An in vitro study of the properties influencing Staphylococcus epidermidis adhesion to prosthetic vascular graft materials.

Authors:  J M Harris; L F Martin
Journal:  Ann Surg       Date:  1987-11       Impact factor: 12.969

2.  Aesthetic considerations in the reconstruction of the anophthalmic orbit.

Authors:  M B Habal
Journal:  Aesthetic Plast Surg       Date:  1987       Impact factor: 2.326

3.  Enhanced cell adhesion to silicone implant material through plasma surface modification.

Authors:  J Hauser; J Zietlow; M Köller; S A Esenwein; H Halfmann; P Awakowicz; H U Steinau
Journal:  J Mater Sci Mater Med       Date:  2009-12       Impact factor: 3.896

4.  Twelve months of experience with Bioplastique.

Authors:  R A Mladick
Journal:  Aesthetic Plast Surg       Date:  1992       Impact factor: 2.326

5.  Polydimethylsiloxane-indomethacin blends and nanoparticles.

Authors:  Carmen Racles
Journal:  AAPS PharmSciTech       Date:  2013-06-13       Impact factor: 3.246

6.  Evaluation of the effects of differences in silicone hardness on rat model of lumbar spinal stenosis.

Authors:  Hyunseong Kim; Jin Young Hong; Wan-Jin Jeon; Junseon Lee; In-Hyuk Ha
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

7.  Development of a surgical procedure for implantation of a prototype suprachoroidal retinal prosthesis.

Authors:  Alexia L Saunders; Chris E Williams; Wilson Heriot; Robert Briggs; Jonthan Yeoh; David A X Nayagam; Mark McCombe; Joel Villalobos; Owen Burns; Chi D Luu; Lauren N Ayton; Michelle McPhedran; Nicholas L Opie; Ceara McGowan; Robert K Shepherd; Robyn Guymer; Penelope J Allen
Journal:  Clin Exp Ophthalmol       Date:  2014-02-07       Impact factor: 4.207

8.  Cerebrospinal fluid (CSF) shunting and ventriculocisternostomy (ETV) in 400 pediatric patients. Shifts in understanding, diagnostics, case-mix, and surgical management during half a century.

Authors:  A Henriette Paulsen; Bernt J Due-Tønnessen; Tryggve Lundar; Karl-Fredrik Lindegaard
Journal:  Childs Nerv Syst       Date:  2016-10-29       Impact factor: 1.475

Review 9.  The Vaginal Microbiota, Bacterial Biofilms and Polymeric Drug-Releasing Vaginal Rings.

Authors:  Louise Carson; Ruth Merkatz; Elena Martinelli; Peter Boyd; Bruce Variano; Teresa Sallent; Robert Karl Malcolm
Journal:  Pharmaceutics       Date:  2021-05-19       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.